Literature DB >> 24258059

Prevalence of Chlamydia trachomatis and herpes simplex virus type 2: Results from the 2009 to 2011 Canadian Health Measures Survey.

Michelle Rotermann1, Kellie A Langlois, Alberto Severini, Stephanie Totten.   

Abstract

BACKGROUND: Chlamydia, caused by Chlamydia trachomatis, and genital herpes, caused by simplex virus type 2 (HSV-2), are common sexually transmitted infections. Their prevalence has been estimated in selected populations, but overall prevalence in Canada is not known. DATA AND METHODS: Data are from the 2009 to 2011 Canadian Health Measures Survey. Socio-demographic, health and lifestyle information was obtained via a household questionnaire; blood and urine collected at a mobile examination centre were used to identify the presence of Chlamydia trachomatis and HSV-2 among 14- to 59-year-olds.
RESULTS: An estimated 13.6% of Canadians (2.9 million) tested positive for HSV-2, and another 0.7% (158,000), for chlamydia. HSV-2 affects higher percentages of women than men, and individuals aged 35 to 59 versus 15 to 34. No significant differences in HSV-2 prevalence were detected by marital status, household income, education, or racial background. Nearly all individuals with laboratory-confirmed chlamydia or HSV-2 were unaware that they were infected.
INTERPRETATION: This study is the first in Canada to report laboratory-confirmed prevalence of chlamydia and HSV-2 using a nationally representative sample. Results suggest that most infected people are unaware of their status.

Entities:  

Keywords:  disease notification; health surveys; sexually transmitted diseases

Mesh:

Year:  2013        PMID: 24258059

Source DB:  PubMed          Journal:  Health Rep        ISSN: 0840-6529            Impact factor:   4.796


  10 in total

1.  Unfortunate synergy between HIV and genital herpes.

Authors: 
Journal:  Can Fam Physician       Date:  2016-02       Impact factor: 3.275

2.  Pathways from Resilient Coping to Safer Sex Communication Among African, Caribbean, and Black Women in Toronto, Canada: Results from a Cross-sectional Survey.

Authors:  Carmen H Logie; Moses Okumu; Shannon Ryan; Mary Yehdego
Journal:  Int J Behav Med       Date:  2018-08

Review 3.  Inflammation and HIV Transmission in Sub-Saharan Africa.

Authors:  Rupert Kaul; Jessica Prodger; Vineet Joag; Brett Shannon; Sergey Yegorov; Ronald Galiwango; Lyle McKinnon
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

4.  Increasing incidence rates of sexually transmitted infections from 2010 to 2019: an analysis of temporal trends by geographical regions and age groups from the 2019 Global Burden of Disease Study.

Authors:  Min Du; Wenxin Yan; Wenzhan Jing; Chenyuan Qin; Qiao Liu; Min Liu; Jue Liu
Journal:  BMC Infect Dis       Date:  2022-06-26       Impact factor: 3.667

5.  Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period.

Authors:  Petra J Woestenberg; Jeroen H T Tjhie; Hester E de Melker; Fiona R M van der Klis; Jan E A M van Bergen; Marianne A B van der Sande; Birgit H B van Benthem
Journal:  BMC Infect Dis       Date:  2016-08-02       Impact factor: 3.090

Review 6.  Antiviral anticoagulation.

Authors:  Edward L G Pryzdial; Michael R Sutherland; Bryan H Lin; Marc Horwitz
Journal:  Res Pract Thromb Haemost       Date:  2020-07-06

7.  Chlamydia in Canada, 2010-2015.

Authors:  Y Choudhri; J Miller; J Sandhu; A Leon; J Aho
Journal:  Can Commun Dis Rep       Date:  2018-02-01

8.  The epidemiology of sexually transmitted co-infections in HIV-positive and HIV-negative African-Caribbean women in Toronto.

Authors:  Robert S Remis; Juan Liu; Mona Loutfy; Wangari Tharao; Anuradha Rebbapragada; Stephen J Perusini; Lisungu Chieza; Megan Saunders; LoriAnn Green-Walker; Rupert Kaul
Journal:  BMC Infect Dis       Date:  2013-11-17       Impact factor: 3.090

Review 9.  Application of Dendrimers for the Treatment of Infectious Diseases.

Authors:  Zandile Mhlwatika; Blessing Atim Aderibigbe
Journal:  Molecules       Date:  2018-08-31       Impact factor: 4.411

10.  Does suppressive antiviral therapy for herpes simplex virus prevent transmission in an HIV-positive population? A systematic review.

Authors:  C R Smith; L Pogany; U Auguste; M Steben; Tty Lau
Journal:  Can Commun Dis Rep       Date:  2016-02-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.